Submission Details
| 510(k) Number | K151378 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 22, 2015 |
| Decision Date | November 24, 2015 |
| Days to Decision | 186 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
K151378 is an FDA 510(k) clearance for the Lumipulse G HE4 Immunoreaction Cartridges, Lumipulse G HE4 Calibrators, a Test, Epithelial Ovarian Tumor Associated Antigen (he4) (Class II — Special Controls, product code OIU), submitted by Fujirebio Diagnostics,Inc. (Malvern, US). The FDA issued a Cleared decision on November 24, 2015, 186 days after receiving the submission on May 22, 2015. This device falls under the Immunology review panel. Regulated under 21 CFR 866.6010.
| 510(k) Number | K151378 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | May 22, 2015 |
| Decision Date | November 24, 2015 |
| Days to Decision | 186 days |
| Submission Type | Traditional |
| Review Panel | Immunology (IM) |
| Summary | Summary PDF |
| Product Code | OIU — Test, Epithelial Ovarian Tumor Associated Antigen (he4) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.6010 |
| Definition | An Enzyme Immunometric Assay For The Quantitative Determination Of He4 In Human Serum. The Assay Is To Be Used As An Aid In Monitoring Recurrence Or Progressive Disease In Patients With Epithelial Ovarian Cancer. Serial Testing For Patient He4 Assay Values Should Be Used In Conjunction With Other Clinical Methods Used For Monitoring Ovarian Cancer. It Is Not Intended To Estimate Or Assess The Risk Of Disease Outcomes Of Patients. |